Cargando…
Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
BACKGROUND: Sclerostin is known to be a canonical Wnt/β-catenin signaling pathway inhibitor, while the Wnt/β-catenin signaling pathway is proposed to be involved in the development of arterial stiffness. This study aims to investigate the relationship between serum sclerostin levels and carotid–femo...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260557/ https://www.ncbi.nlm.nih.gov/pubmed/30482161 http://dx.doi.org/10.1186/s12872-018-0955-5 |